Variant #0001059531 (NC_000005.9:g.176832417_176832418del, NM_000505.3:c.303_304del (F12))
| Individual ID |
00469721 |
| Chromosome |
5 |
| Allele |
Paternal (confirmed) |
| Affects function (as reported) |
Probably affects function |
| Affects function (by curator) |
Probably affects function |
| Classification method |
ACMG |
| Clinical classification |
likely pathogenic |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.176832417_176832418del |
| DNA change (hg38) |
g.177405416_177405417del |
| Published as |
- |
| ISCN |
- |
| DB-ID |
F12_000077 |
| Variant remarks |
Attributed in ClinVar by Juno Genomics, Hangzhou China, as a Factor XII deficiency disease variant. HAE symptoms of proband fully resolved following lanadelumab, consistent with bradykinin-pathway modulation, but not by icatibant, discarding an involvement of a bradykinin-dependent phenotype. The father is an asymptomatic carrier. Considered as likely pathogenic with criteria PVS1+PM2 by Gao 2025. Next in 2026, the variant has been requalified as leading to FXII deficiency due to a secretion defect, which is unrelated to the pathogenesis of HAE-FXII; classifying the frameshift variant p.(His101Glnfs36) as causative for HAE-FXII is misleading. |
| Reference |
PubMed: Gao 2025, Journal: Gao 2025 Journal: Myiata 2026 |
| ClinVar ID |
ClinVar-SCV005416608.2 |
| dbSNP ID |
- |
| Origin |
Germline |
| Segregation |
- |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
2.0E-5 View details |
| Owner |
Christian Drouet |
| Database submission license |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
| Created by |
Christian Drouet |
| Date created |
2025-11-19 14:30:20 +01:00 (CET) |
| Date last edited |
2026-06-09 11:21:46 +02:00 (CEST) |

Variant on transcripts
Screenings
|